Immunotherapies work on various parts of the immune system, and researchers are developing new ones all the time. The most common types in use today include checkpoint inhibitors, monoclonal antibodies, therapeutic cancer vaccines, and CAR T-cell therapy.
Checkpoint Inhibitors
Checkpoint inhibitors, (also called immune checkpoint inhibitors) block proteins that act like “off switches” for your immune system (4). These checkpoint proteins normally sit on the surface of T cells, immune cells that hunt down harmful cells. Checkpoint proteins control T cell activity and put the brakes on when needed, preventing them from becoming too aggressive and attacking healthy cells. However, cancer cells can hijack these switches, tricking your T cells into standing down instead of attacking.
Checkpoint inhibitor drugs prevent T cells from hitting the brakes when they encounter cancer cells, allowing your immune cells to do their job, recognising and killing cancer cells. There are several types of checkpoint inhibitor drugs, including PD-1, CTLA-4, and LAG-3 inhibitors. Each targets a specific checkpoint protein (4).
Monoclonal Antibodies (mAbs)
One of the ways the immune system helps keep you healthy is by making antibodies, proteins that attach to specific antigens, or targets on harmful cells and remove them from your body. Monoclonal antibodies are made in a lab and designed to mimic this natural process, targeting antigens found on cancer cells.
Monoclonal antibodies can act as both immunotherapy and targeted therapy. They help your immune system find and attack cancer cells more effectively, while also attaching to specific targets that are more common on cancer cells, helping treatment focus its effects while potentially reducing damage to healthy tissues (4).
Monoclonal antibodies work by (4):
- Flagging cancer cells for destruction.
- Blocking proteins that cancer cells need to grow.
- Delivering toxins into cancer cells to kill them.
- Targeting weaknesses in cancer cells to stop their growth.
Vaccines to Treat Cancer
Unlike vaccines that prevent cancer, like the HPV vaccine, cancer treatment vaccines help your body fight cancer you already have. The vaccines target antigens found on cancer cells, and help your body remember them long after treatment ends.
They may (2):
- Kill cancer cells left behind after treatment.
- Slow or stop tumour growth.
- Prevent cancer cells from returning.
Cancer vaccine immunotherapies are commonly used to treat early-stage bladder cancer, and some forms of melanoma. Many more vaccines are in development.
CAR T-Cell Therapy
CAR T-cell therapy is a personalised treatment made from white blood cells taken from your body. Doctors remove T cells from your blood, add a lab-made protein that helps T cells find and kill cancer cells, called chimeric antigen receptor (CAR), to their surface, and grow millions of copies in a lab. These modified CAR T-cells are then infused back into your bloodstream, where they travel through your body to hunt down cancer cells (4).
It’s commonly used to treat leukaemia and lymphoma, and doctors are studying its use in other cancers.